MoneyWorks4Me

The Revenue for the quarter ended  March 2022 of Rs. 40068.80 millions grew by 9.26 % from Rs. 36672.60 millions.The Net Loss for the quarter ended March 2022 is Rs. -12862.10 millions as compared to Net Profit of Rs. 1848.80 millions of corresponding quarter ended March 2021Operating profit surged to 13002.50 millions from the corresponding previous quarter of 7455.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 40068.80 36672.60 9.26 155859.80 141160.50 10.41 155859.80 141160.50 10.41
Other Income 4404.90 382.70 1051.01 11968.80 1920.70 523.15 11968.80 1920.70 523.15
PBIDT 13002.50 7455.00 74.41 38654.40 24490.80 57.83 38654.40 24490.80 57.83
Interest 911.90 1053.10 -13.41 3881.00 2675.20 45.07 3881.00 2675.20 45.07
PBDT -4459.00 5506.30 -180.98 16568.10 20920.00 -20.80 16568.10 20920.00 -20.80
Depreciation 3541.40 3220.70 9.96 13499.50 12364.30 9.18 13499.50 12364.30 9.18
PBT -8000.40 2285.60 -450.04 3068.60 8555.70 -64.13 3068.60 8555.70 -64.13
TAX 4861.70 436.80 1013.03 4068.50 131.70 2989.22 4068.50 131.70 2989.22
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -12862.10 1848.80 -795.70 -999.90 8424.00 -111.87 -999.90 8424.00 -111.87
Equity 2399.30 2399.30 0.00 2399.30 2399.30 0.00 2399.30 2399.30 0.00
PBIDTM(%) 32.45 20.33 59.63 24.80 17.35 42.95 24.80 17.35 42.95
Peers
Company Name CMP
Sun Pharma. Inds. 1782.00
Dr. Reddys Labs. 1208.00
Cipla 1334.00
Lupin 2010.00
Zydus Lifesciences 1138.50
View more..